Belucie Luxury Timeless Golden Age Eye

Manufacturer
KIMJEONGMOON ALOE CO., LTD. | COSMAX INC.
Effective date
2012-11-29
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:33:51

Label at a glance#

ProductBelucie Luxury Timeless Golden Age Eye
Active ingredientDimethicone
Label structure8 sections

Indications and uses

Indication and usage 1. Recap the bottle after use. 2. Avoid exposure to a high or low temperature of direct sunlight

Dosage and administration

Dosage and administration Spread gently around eye to take out suitable amount and tap with your finger lightly

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient: Dimethicone 5%

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

Inactive Ingredients:
Aloe Barbadensis Leaf Extract, Butylene Glycol, Hydrogenated Poly(C6-14 Olefin),Macadamia Integrifolia Seed Oil,Cetyl Ethylhexanoate,Glyceryl Stearate,Butyrospermum Parkii (Shea) Butter,PEG-100 Stearate,Bis-Diglyceryl Polyacyladipate-2,Niacinamide,Cetearyl Alcohol,Sorbitol,Water,Methylparaben,Fragrance(Parfum), Phenoxyethanol,Propylparaben,BHT,Tocopheryl Acetate,Adenosine,Triethanolamine,Carbomer,Lecithin,Alcohol, Butylparaben,Ethylparaben,Isobutylparaben,Glycerin,Disodium EDTA,Caramel,Polysorbate 80,Vitis Vinifera (Grape) Seed Oil,Saccharomyces/Xylinum/Black Tea Ferment,Caprylic/Capric Triglyceride,Argania Spinosa Kernel Extract,Yellow 6 (CI 15985),Yellow 5 (CI 19140),Sigesbeckia Orientalis Extract,Benzimidazole Diamond Amidoethyl Urea Carbamoyl Propyl Polymethylsilsesquioxane,Tremella fuciformis Sporocarp Extract,Rabdosia Rubescens Extract,Hydroxyethylcellulose,
Sodium Ascorbyl Phosphate,Caviar Extract,Sodium Cocoyl Glutamate,Potassium Sorbate,Platinum Powder

PURPOSE

OTC - PURPOSE SECTION

Purpose: Skin Protectant

WARNINGS

WARNINGS SECTION

Warnings
1. In case of having following symptoms after using this, you’re advised to stop using it immediately. If you keep using it, the symptoms will get worse and need to consult a dematologists.
2. In case of having problems such as red spots, swelling, itching and irritation during usage
3. In case the above symptoms emerge due to direct exposure to sunlight
4. Please do not apply the skin to areas affected by eczema and dermatitis

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

Indication and usage
1. Recap the bottle after use.
2. Avoid exposure to a high or low temperature of direct sunlight

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Dosage and administration
Spread gently around eye to take out suitable amount and tap with your finger lightly

PACKAGE LABEL. PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Image of cartonImage of carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
259090dimethicone 5 % Topical CreamPSN1
259090dimethicone 50 MG/ML Topical CreamSCD1
259090dimethicone 5 % Topical CreamSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
DIMETHICONE Pharmacologic Class Indexing3Indexing - Pharmacologic Class20180813

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
50410-050-012020-01-31C16284748780-19d75b9d0-6733-f424-e053-dadaa90a57ced0d219bf-6ec1-4fc5-900d-9c7c88f004cc

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
50410-050-01Belucie Luxury Timeless Golden Age Eye30 mL in 1 CARTONCREAM301

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
50410-050BELUCIE LUXURY TIMELESS GOLDEN AGE EYE (DIMETHICONE) CREAM [KIMJEONGMOON ALOE CO., LTD.]1Legacy NDC, 1 package rows20121129_d0d219bf-6ec1-4fc5-900d-9c7c88f004cc.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
DimethiconeACTIVE INGREDIENT92RU3N3Y1O1
DIMETHICONEACTIVE MOIETY92RU3N3Y1O1
ALOE VERA LEAFINACTIVE INGREDIENTZY81Z83H0X1
Butylene GlycolINACTIVE INGREDIENT3XUS85K0RA1
Cetyl EthylhexanoateINACTIVE INGREDIENT134647WMX41
SHEA BUTTERINACTIVE INGREDIENTK49155WL9Y1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
50410-05050410-050-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 3 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
Butylene GlycolBUTYLENE GLYCOL3XUS85K0RASYSTEM / TOPICAL1400 mgExact identifier — unii candidate
2 equally ranked IID candidates
SHEA BUTTERSHEA BUTTERK49155WL9YLOTION / TOPICAL2340 mgExact identifier — unii candidate
Butylene GlycolBUTYLENE GLYCOL3XUS85K0RASYSTEM / TRANSDERMAL8.12 mgExact identifier — unii candidate
2 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
dd2997d9-df75-4445-9122-a9f5b864c317d0d219bf-6ec1-4fc5-900d-9c7c88f004cc2012-11-29WarningsExact identifier
spl id: dd2997d9-df75-4445-9122-a9f5b864c317
spl set id: d0d219bf-6ec1-4fc5-900d-9c7c88f004cc

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.